Hologic Wins Patent Dispute Against Siemens Over Mammography Technology
The Unified Patent Court ordered a recall and destruction of infringing breast cancer screening systems in Germany, France, and the Netherlands.
The Unified Patent Court ordered a recall and destruction of infringing breast cancer screening systems in Germany, France, and the Netherlands.
A study of 110,000 women identified a correlation between GLP-1 use and reduced breast cancer incidence, though researchers caution the findings do not establish causation.
Researchers found that neither radiologists nor leading AI models could consistently distinguish real from AI-generated X-rays, highlighting emerging risks in medical imaging and cybersecurity.
The ACP issued new guidance recommending biennial screening mammography for asymptomatic, average-risk women ages 50 to 74.